SOURCE: Healtheuniverse, Inc.

September 11, 2006 16:00 ET

Healtheuniverse Signs Clinical Research and Marketing Agreement With The California Institute of Cosmetic and Reconstructive Surgery for Fat Based Stem Cell Technology and Products

COVINA, CA -- (MARKET WIRE) -- September 11, 2006 -- Healtheuniverse, Inc. (PINKSHEETS: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, announced today that it has entered into an agreement with The California Institute of Cosmetic and Reconstructive Surgery (C.I.C.R.S.) for clinical research, marketing and distribution rights for fat based stem cell technology and products in the United States. The agreement provides for CICRS to conduct clinical trials in the United States for fat based stem cell applications in the areas of cosmetic, plastic, and reconstructive surgery. CICRS grants Healtheuniverse patent, technology, IP, and licensing rights to market and sell products developed by these clinical trials, if they are approved for marketing.

Under the terms of this agreement, CICRS will manage a series of clinical trials intended to examine the safety and efficacy of fat based stem cell therapies for the treatment of cosmetic, plastic, and reconstructive patients. Healtheuniverse will be responsible for managing and funding the clinical trials and all necessary regulatory registrations for products in the United States. Upon regulatory approval of the products, Healtheuniverse will be the exclusive distributor of products cleared for marketing. Financial terms of the agreement were not disclosed.

About The California Institute of Cosmetic and Reconstructive Surgery

Services at The California Institute of Cosmetic & Reconstructive Surgery range from the latest techniques in Cosmetic Surgery to extensive new developments in the field of Reconstructive Surgery. The Institute performs Cosmetic Surgery such as breast augmentation, facelifts, liposuction, and rhinoplasty, as well as extensive Reconstructive Surgery for Breast Cancer, burn victims, trauma victims, chronic wounds, skin cancer, and hand surgery.

About HEALTHeUNIVERSE, Inc.

HEALTHeUNIVERSE, Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. We are engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications. More information on Healtheuniverse is available online at http://healtheuniverse.com/

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse, Inc., and members of their management as well as the assumptions on which such statements are based. This press release replaces the previously issued press release on April 10th, 2006 in which Healtheuniverse announced it had acquired the California Institute of Cosmetic and Reconstructive Surgery. Reasons for rescinding the acquisition agreement include liability concerns related to owning an operating clinic and also the legitimacy of results produced in the clinical trials if CICRS was owned by Healtheuniverse. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    800-719-7424
    Email Contact